{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:31:51Z","timestamp":1793939511582,"version":"4.8.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41569-024-01056-4","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T13:01:42Z","timestamp":1720616502000},"page":"880-898","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Consequences of ionizing radiation exposure to the cardiovascular system"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-6567","authenticated-orcid":false,"given":"James W. S.","family":"Jahng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0980-7567","authenticated-orcid":false,"given":"Mark P.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-5141","authenticated-orcid":false,"given":"Hyunsoo J.","family":"No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-0544","authenticated-orcid":false,"suffix":"Jr","given":"Billy W.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-8041","authenticated-orcid":false,"given":"Joseph C.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"1056_CR1","unstructured":"United Nations. Radiation Effects and Sources: What is Radiation? What Does Radiation do to us? Where Does Radiation Come From? https:\/\/www.unep.org\/resources\/report\/radiation-effects-and-sources (United Nations Environment Programme, 2017)."},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1038\/sj.onc.1206663","volume":"22","author":"RB Mikkelsen","year":"2003","unstructured":"Mikkelsen, R. B. & Wardman, P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 22, 5734\u20135754 (2003).","journal-title":"Oncogene"},{"key":"1056_CR3","first-page":"376","volume":"123","author":"Y Jiao","year":"2022","unstructured":"Jiao, Y., Cao, F. & Liu, H. Radiation-induced cell death and its mechanisms. Health Phys. 123, 376\u2013386 (2022).","journal-title":"Health Phys."},{"key":"1056_CR4","unstructured":"Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 (National Academies Press, 2006)."},{"key":"1056_CR5","unstructured":"ICRP. ICRP Publication 103: Recommendations of the ICRP. https:\/\/www.icrp.org\/publication.asp?id=ICRP%20Publication%20103 (Elsevier Science, 2007)."},{"key":"1056_CR6","unstructured":"ICRP. ICRP Publication 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs \u2014 Threshold Doses for Tissue Reactions in a Radiation Protection Context. https:\/\/journals.sagepub.com\/doi\/10.1016\/j.icrp.2012.02.001 (Elsevier Science, 2012)."},{"key":"1056_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrc1950","volume":"6","author":"SM Bentzen","year":"2006","unstructured":"Bentzen, S. M. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat. Rev. Cancer 6, 702\u2013713 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1056_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrc1277","volume":"4","author":"C Mothersill","year":"2004","unstructured":"Mothersill, C. & Seymour, C. B. Radiation-induced bystander effects \u2014 implications for cancer. Nat. Rev. Cancer 4, 158\u2013164 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mrrev.2012.12.001","volume":"752","author":"M Kadhim","year":"2013","unstructured":"Kadhim, M. et al. Non-targeted effects of ionising radiation \u2014 implications for low dose risk. Mutat. Res. 752, 84\u201398 (2013).","journal-title":"Mutat. Res."},{"key":"1056_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer \u2014 role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619\u2013636 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cancers11091236","volume":"11","author":"C Mothersill","year":"2019","unstructured":"Mothersill, C., Rusin, A. & Seymour, C. Relevance of non-targeted effects for radiotherapy and diagnostic radiology; a historical and conceptual analysis of key players. Cancers 11, 1236 (2019).","journal-title":"Cancers"},{"key":"1056_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-072924","volume":"380","author":"MP Little","year":"2023","unstructured":"Little, M. P. et al. Ionising radiation and cardiovascular disease: systematic review and meta-analysis. BMJ 380, e072924 (2023).","journal-title":"BMJ"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/09553002.2021.1876955","volume":"97","author":"MP Little","year":"2021","unstructured":"Little, M. P., Azizova, T. V. & Hamada, N. Low- and moderate-dose non-cancer effects of ionizing radiation in directly exposed individuals, especially circulatory and ocular diseases: a review of the epidemiology. Int. J. Radiat. Biol. 97, 782\u2013803 (2021).","journal-title":"Int. J. Radiat. Biol."},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1289\/ehp.1204982","volume":"120","author":"MP Little","year":"2012","unstructured":"Little, M. P. et al. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ. Health Perspect. 120, 1503\u20131511 (2012).","journal-title":"Environ. Health Perspect."},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"b5349","DOI":"10.1136\/bmj.b5349","volume":"340","author":"Y Shimizu","year":"2010","unstructured":"Shimizu, Y. et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950\u20132003. BMJ 340, b5349 (2010).","journal-title":"BMJ"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1667\/RR14347.1","volume":"187","author":"I Takahashi","year":"2017","unstructured":"Takahashi, I. et al. Heart disease mortality in the life span study, 1950\u20132008. Radiat. Res. 187, 319\u2013332 (2017).","journal-title":"Radiat. Res."},{"key":"1056_CR17","unstructured":"No, N. C. Implications of Recent Epidemiologic Studies for the Linear Nonthreshold Model and Radiation Protection (NCRP, 2018)."},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1667\/RR13680.1","volume":"182","author":"TV Azizova","year":"2014","unstructured":"Azizova, T. V., Haylock, R. G., Moseeva, M. B., Bannikova, M. V. & Grigoryeva, E. S. Cerebrovascular diseases incidence and mortality in an extended Mayak Worker Cohort 1948\u20131982. Radiat. Res. 182, 529\u2013544 (2014).","journal-title":"Radiat. Res."},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1088\/0952-4746\/35\/3\/517","volume":"35","author":"TV Azizova","year":"2015","unstructured":"Azizova, T. V., Grigorieva, E. S., Hunter, N., Pikulina, M. V. & Moseeva, M. B. Risk of mortality from circulatory diseases in Mayak workers cohort following occupational radiation exposure. J. Radiol. Prot. 35, 517\u2013538 (2015).","journal-title":"J. Radiol. Prot."},{"key":"1056_CR20","doi-asserted-by":"publisher","first-page":"20150169","DOI":"10.1259\/bjr.20150169","volume":"88","author":"TV Azizova","year":"2015","unstructured":"Azizova, T. V., Grigoryeva, E. S., Haylock, R. G., Pikulina, M. V. & Moseeva, M. B. Ischaemic heart disease incidence and mortality in an extended cohort of Mayak workers first employed in 1948\u20131982. Br. J. Radiol. 88, 20150169 (2015).","journal-title":"Br. J. Radiol."},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00411-016-0645-6","volume":"55","author":"TV Azizova","year":"2016","unstructured":"Azizova, T. V., Bannikova, M. V., Grigorieva, E. S., Bagaeva, Y. P. & Azizova, E. V. Risk of lower extremity arterial disease in a cohort of workers occupationally exposed to ionizing radiation over a prolonged period. Radiat. Environ. Biophys. 55, 147\u2013159 (2016).","journal-title":"Radiat. Environ. Biophys."},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00411-022-00966-6","volume":"61","author":"TV Azizova","year":"2022","unstructured":"Azizova, T. V., Moseeva, M. B., Grigoryeva, E. S. & Hamada, N. Incidence risks for cerebrovascular diseases and types of stroke in a cohort of Mayak PA workers. Radiat. Environ. Biophys. 61, 5\u201316 (2022).","journal-title":"Radiat. Environ. Biophys."},{"key":"1056_CR23","doi-asserted-by":"publisher","unstructured":"Azizova, T. V., Bannikova, M. V., Grigoryeva, E. S., Briks, K. V. & Hamada, N. Mortality from various diseases of the circulatory system in the Russian Mayak nuclear worker cohort: 1948\u20132018. J. Radiol. Prot. https:\/\/doi.org\/10.1088\/1361-6498\/ac4ae3 (2022).","DOI":"10.1088\/1361-6498\/ac4ae3"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/HYPERTENSIONAHA.118.11719","volume":"73","author":"T Azizova","year":"2019","unstructured":"Azizova, T., Briks, K., Bannikova, M. & Grigoryeva, E. Hypertension incidence risk in a cohort of Russian workers exposed to radiation at the Mayak production association over prolonged periods. Hypertension 73, 1174\u20131184 (2019).","journal-title":"Hypertension"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.HP.0000175835.31663.ea","volume":"90","author":"VK Ivanov","year":"2006","unstructured":"Ivanov, V. K. et al. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 90, 199\u2013207 (2006).","journal-title":"Health Phys."},{"key":"1056_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/HP.0000000000000670","volume":"113","author":"VV Kashcheev","year":"2017","unstructured":"Kashcheev, V. V. et al. Radiation risk of cardiovascular diseases in the cohort of Russian emergency workers of the Chernobyl accident. Health Phys. 113, 23\u201329 (2017).","journal-title":"Health Phys."},{"key":"1056_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/HP.0000000000000523","volume":"111","author":"VV Kashcheev","year":"2016","unstructured":"Kashcheev, V. V. et al. Radiation-epidemiological study of cerebrovascular diseases in the cohort of Russian recovery operation workers of the Chernobyl accident. Health Phys. 111, 192\u2013197 (2016).","journal-title":"Health Phys."},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00411-012-0438-5","volume":"52","author":"LY Krestinina","year":"2013","unstructured":"Krestinina, L. Y. et al. Chronic low-dose exposure in the Techa River cohort: risk of mortality from circulatory diseases. Radiat. Environ. Biophys. 52, 47\u201357 (2013).","journal-title":"Radiat. Environ. Biophys."},{"key":"1056_CR29","doi-asserted-by":"publisher","unstructured":"Wakeford, R. Risk of diseases of the circulatory system after low-level radiation exposure \u2014 an assessment of evidence from occupational exposures. J. Radiol. Prot. https:\/\/doi.org\/10.1088\/1361-6498\/ac6275 (2022).","DOI":"10.1088\/1361-6498\/ac6275"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1096\/fj.04-3287fje","volume":"19","author":"MG Andreassi","year":"2005","unstructured":"Andreassi, M. G. et al. Somatic DNA damage in interventional cardiologists: a case\u2013control study. FASEB J. 19, 998\u2013999 (2005).","journal-title":"FASEB J."},{"key":"1056_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/em.21917","volume":"56","author":"A Borghini","year":"2015","unstructured":"Borghini, A. et al. Increased circulating cell-free DNA levels and mtDNA fragments in interventional cardiologists occupationally exposed to low levels of ionizing radiation. Environ. Mol. Mutagen. 56, 293\u2013300 (2015).","journal-title":"Environ. Mol. Mutagen."},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","volume":"76","author":"SC Darby","year":"2010","unstructured":"Darby, S. C. et al. Radiation-related heart disease: current knowledge and future prospects. Int. J. Radiat. Oncol. Biol. Phys. 76, 656\u2013665 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurheartj\/ehr281","volume":"33","author":"AJ Einstein","year":"2012","unstructured":"Einstein, A. J. & Knuuti, J. Cardiac imaging: does radiation matter? Eur. Heart J. 33, 573\u2013578 (2012).","journal-title":"Eur. Heart J."},{"key":"1056_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/oemed-2015-102888","volume":"73","author":"P Rajaraman","year":"2016","unstructured":"Rajaraman, P. et al. Incidence and mortality risks for circulatory diseases in US radiologic technologists who worked with fluoroscopically guided interventional procedures, 1994\u20132008. Occup. Environ. Med. 73, 21\u201327 (2016).","journal-title":"Occup. Environ. Med."},{"key":"1056_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1259\/bjr.74.882.740507","volume":"74","author":"A Berrington","year":"2001","unstructured":"Berrington, A., Darby, S. C., Weiss, H. A. & Doll, R. 100 years of observation on British radiologists: mortality from cancer and other causes 1897\u20131997. Br. J. Radiol. 74, 507\u2013519 (2001).","journal-title":"Br. J. Radiol."},{"key":"1056_CR36","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/ije\/dym138","volume":"36","author":"M Vrijheid","year":"2007","unstructured":"Vrijheid, M. et al. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int. J. Epidemiol. 36, 1126\u20131135 (2007).","journal-title":"Int. J. Epidemiol."},{"key":"1056_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1667\/RR14608.1","volume":"188","author":"M Gillies","year":"2017","unstructured":"Gillies, M. et al. Mortality from circulatory diseases and other non-cancer outcomes among nuclear workers in France, the United Kingdom and the United States (INWORKS). Radiat. Res. 188, 276\u2013290 (2017).","journal-title":"Radiat. Res."},{"key":"1056_CR38","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1667\/RR0552.1","volume":"167","author":"I Thierry-Chef","year":"2007","unstructured":"Thierry-Chef, I. et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: study of errors in dosimetry. Radiat. Res. 167, 380\u2013395 (2007).","journal-title":"Radiat. Res."},{"key":"1056_CR39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1667\/RR14006.1","volume":"183","author":"I Thierry-Chef","year":"2015","unstructured":"Thierry-Chef, I. et al. Dose estimation for a study of nuclear workers in France, the United Kingdom and the United States of America: methods for the international nuclear workers study (INWORKS). Radiat. Res. 183, 632\u2013642 (2015).","journal-title":"Radiat. Res."},{"key":"1056_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13246-023-01226-7","volume":"46","author":"KS Wilson-Stewart","year":"2023","unstructured":"Wilson-Stewart, K. S., Fontanarosa, D., Malacova, E. & Trapp, J. V. Fluoroscopically guided vascular and cardiac transcatheter procedures: a comparison of occupational and patient dose by anatomical region. Phys. Eng. Sci. Med. 46, 353\u2013365 (2023).","journal-title":"Phys. Eng. Sci. Med."},{"key":"1056_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.003273","volume":"9","author":"MG Andreassi","year":"2016","unstructured":"Andreassi, M. G. et al. Occupational health risks in cardiac catheterization laboratory workers. Circ. Cardiovasc. Interv. 9, e003273 (2016).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"1056_CR42","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.3390\/ijms22147504","volume":"22","author":"C Baudin","year":"2021","unstructured":"Baudin, C., Bernier, M. O., Klokov, D. & Andreassi, M. G. Biomarkers of genotoxicity in medical workers exposed to low-dose ionizing radiation: systematic review and meta-analyses. Int. J. Mol. Sci. 22, 7504 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1056_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/eurheartj\/ehr263","volume":"33","author":"GL Russo","year":"2012","unstructured":"Russo, G. L. et al. Cellular adaptive response to chronic radiation exposure in interventional cardiologists. Eur. Heart J. 33, 408\u2013414 (2012).","journal-title":"Eur. Heart J."},{"key":"1056_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/oemed-2023-108865","volume":"80","author":"CE Peters","year":"2023","unstructured":"Peters, C. E., Quinn, E. K., Rodriguez-Villamizar, L. A., MacDonald, H. & Villeneuve, P. J. Exposure to low-dose radiation in occupational settings and ischaemic heart disease: a systematic review and meta-analysis. Occup. Environ. Med. 80, 706\u2013714 (2023).","journal-title":"Occup. Environ. Med."},{"key":"1056_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep44147","volume":"7","author":"V Tran","year":"2017","unstructured":"Tran, V., Zablotska, L. B., Brenner, A. V. & Little, M. P. Radiation-associated circulatory disease mortality in a pooled analysis of 77,275 patients from the Massachusetts and Canadian tuberculosis fluoroscopy cohorts. Sci. Rep. 7, 44147 (2017).","journal-title":"Sci. Rep."},{"key":"1056_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/0955300021000038662","volume":"79","author":"T Hayashi","year":"2003","unstructured":"Hayashi, T. et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int. J. Radiat. Biol. 79, 129\u2013136 (2003).","journal-title":"Int. J. Radiat. Biol."},{"key":"1056_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjmed.2004.06.045","volume":"118","author":"T Hayashi","year":"2005","unstructured":"Hayashi, T. et al. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am. J. Med. 118, 83\u201386 (2005).","journal-title":"Am. J. Med."},{"key":"1056_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1667\/RR1070.1","volume":"169","author":"MP Little","year":"2008","unstructured":"Little, M. P. et al. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat. Res. 169, 99\u2013109 (2008).","journal-title":"Radiat. Res."},{"key":"1056_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00018-018-2956-z","volume":"76","author":"B Baselet","year":"2019","unstructured":"Baselet, B., Sonveaux, P., Baatout, S. & Aerts, A. Pathological effects of ionizing radiation: endothelial activation and dysfunction. Cell. Mol. Life Sci. 76, 699\u2013728 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"1056_CR50","doi-asserted-by":"publisher","first-page":"31263","DOI":"10.18632\/oncotarget.5075","volume":"6","author":"M Mancuso","year":"2015","unstructured":"Mancuso, M. et al. Acceleration of atherogenesis in ApoE\u2212\/\u2212 mice exposed to acute or low-dose-rate ionizing radiation. Oncotarget 6, 31263\u201331271 (2015).","journal-title":"Oncotarget"},{"key":"1056_CR51","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.3390\/cancers15133417","volume":"15","author":"O Azimzadeh","year":"2023","unstructured":"Azimzadeh, O. et al. Late effects of chronic low dose rate total body irradiation on the heart proteome of ApoE(\u2212\/\u2212) mice resemble premature cardiac ageing. Cancers 15, 3417 (2023).","journal-title":"Cancers"},{"key":"1056_CR52","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/HP.0b013e31827dbf60","volume":"104","author":"VV Khokhryakov","year":"2013","unstructured":"Khokhryakov, V. V. et al. Mayak Worker Dosimetry System 2008 (MWDS-2008): assessment of internal dose from measurement results of plutonium activity in urine. Health Phys. 104, 366\u2013378 (2013).","journal-title":"Health Phys."},{"key":"1056_CR53","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3390\/cancers11111789","volume":"11","author":"IV Mavragani","year":"2019","unstructured":"Mavragani, I. V., Nikitaki, Z., Kalospyros, S. A. & Georgakilas, A. G. Ionizing radiation and complex DNA damage: from prediction to detection challenges and biological significance. Cancers 11, 1789 (2019).","journal-title":"Cancers"},{"key":"1056_CR54","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","volume":"14","author":"M Durante","year":"2017","unstructured":"Durante, M., Orecchia, R. & Loeffler, J. S. Charged-particle therapy in cancer: clinical uses and future perspectives. Nat. Rev. Clin. Oncol. 14, 483\u2013495 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1056_CR55","doi-asserted-by":"publisher","first-page":"104086","DOI":"10.1016\/j.isci.2022.104086","volume":"25","author":"M Bishawi","year":"2022","unstructured":"Bishawi, M. et al. Late onset cardiovascular dysfunction in adult mice resulting from galactic cosmic ray exposure. iScience 25, 104086 (2022).","journal-title":"iScience"},{"key":"1056_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lssr.2019.01.003","volume":"20","author":"JW Seawright","year":"2019","unstructured":"Seawright, J. W. et al. Effects of low-dose oxygen ions and protons on cardiac function and structure in male C57BL\/6J mice. Life Sci. Space Res. 20, 72\u201384 (2019).","journal-title":"Life Sci. Space Res."},{"key":"1056_CR57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.mrrev.2016.07.008","volume":"770","author":"MP Little","year":"2016","unstructured":"Little, M. P. Radiation and circulatory disease. Mutat. Res. Rev. Mutat. Res. 770, 299\u2013318 (2016).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"1056_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00411-021-00955-1","volume":"61","author":"Y Semenova","year":"2022","unstructured":"Semenova, Y. et al. Epidemiology of stroke and transient ischemic attacks in the population of the territories adjacent to the former Semipalatinsk Nuclear Test Site, Kazakhstan. Radiat. Environ. Biophys. 61, 17\u201328 (2022).","journal-title":"Radiat. Environ. Biophys."},{"key":"1056_CR59","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1161\/CIRCULATIONAHA.107.738732","volume":"117","author":"D Mozaffarian","year":"2008","unstructured":"Mozaffarian, D., Wilson, P. W. & Kannel, W. B. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 117, 3031\u20133038 (2008).","journal-title":"Circulation"},{"key":"1056_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrcardio.2009.53","volume":"6","author":"AJ Einstein","year":"2009","unstructured":"Einstein, A. J. Medical imaging: the radiation issue. Nat. Rev. Cardiol. 6, 436\u2013438 (2009).","journal-title":"Nat. Rev. Cardiol."},{"key":"1056_CR61","doi-asserted-by":"publisher","first-page":"20210389","DOI":"10.1259\/bjr.20210389","volume":"94","author":"C Brower","year":"2021","unstructured":"Brower, C. & Rehani, M. M. Radiation risk issues in recurrent imaging. Br. J. Radiol. 94, 20210389 (2021).","journal-title":"Br. J. Radiol."},{"key":"1056_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","volume":"5","author":"D De Ruysscher","year":"2019","unstructured":"De Ruysscher, D. et al. Radiotherapy toxicity. Nat. Rev. Dis. Prim. 5, 13 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1056_CR63","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","volume":"309","author":"MM Hudson","year":"2013","unstructured":"Hudson, M. M. et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309, 2371\u20132381 (2013).","journal-title":"JAMA"},{"key":"1056_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/M15-0424","volume":"164","author":"DA Mulrooney","year":"2016","unstructured":"Mulrooney, D. A. et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann. Intern. Med. 164, 93\u2013101 (2016).","journal-title":"Ann. Intern. Med."},{"key":"1056_CR65","doi-asserted-by":"publisher","first-page":"l6794","DOI":"10.1136\/bmj.l6794","volume":"368","author":"DA Mulrooney","year":"2020","unstructured":"Mulrooney, D. A. et al. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort. BMJ 368, l6794 (2020).","journal-title":"BMJ"},{"key":"1056_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1667\/RR3525.1","volume":"166","author":"M Stovall","year":"2006","unstructured":"Stovall, M. et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat. Res. 166, 141\u2013157 (2006).","journal-title":"Radiat. Res."},{"key":"1056_CR67","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","volume":"28","author":"M Tukenova","year":"2010","unstructured":"Tukenova, M. et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J. Clin. Oncol. 28, 1308\u20131315 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.115.016686","volume":"133","author":"N Haddy","year":"2016","unstructured":"Haddy, N. et al. Cardiac diseases following childhood cancer treatment: cohort study. Circulation 133, 31\u201338 (2016).","journal-title":"Circulation"},{"key":"1056_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/ejhf.1376","volume":"21","author":"I Mansouri","year":"2019","unstructured":"Mansouri, I. et al. The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer. Eur. J. Heart Fail. 21, 509\u2013518 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1056_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","volume":"3","author":"C Bergom","year":"2021","unstructured":"Bergom, C. et al. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC CardioOncol. 3, 343\u2013359 (2021).","journal-title":"JACC CardioOncol."},{"key":"1056_CR71","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","volume":"270","author":"SL Hancock","year":"1993","unstructured":"Hancock, S. L., Tucker, M. A. & Hoppe, R. T. Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease. JAMA 270, 1949\u20131955 (1993).","journal-title":"JAMA"},{"key":"1056_CR72","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","volume":"109","author":"BM Aleman","year":"2007","unstructured":"Aleman, B. M. et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109, 1878\u20131886 (2007).","journal-title":"Blood"},{"key":"1056_CR73","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1182\/blood-2010-06-291328","volume":"117","author":"SL Galper","year":"2011","unstructured":"Galper, S. L. et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117, 412\u2013418 (2011).","journal-title":"Blood"},{"key":"1056_CR74","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"FA van Nimwegen","year":"2015","unstructured":"van Nimwegen, F. A. et al. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern. Med. 175, 1007\u20131017 (2015).","journal-title":"JAMA Intern. Med."},{"key":"1056_CR75","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","volume":"17","author":"N Bhakta","year":"2016","unstructured":"Bhakta, N. et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin\u2019s lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol. 17, 1325\u20131334 (2016).","journal-title":"Lancet Oncol."},{"key":"1056_CR76","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","volume":"2","author":"MV Maraldo","year":"2015","unstructured":"Maraldo, M. V. et al. Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2, e492\u2013e502 (2015).","journal-title":"Lancet Haematol."},{"key":"1056_CR77","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","volume":"98","author":"E Hahn","year":"2017","unstructured":"Hahn, E. et al. Late cardiac toxicity after mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose\u2013volume variables to risk prediction. Int. J. Radiat. Oncol. Biol. Phys. 98, 1116\u20131123 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR78","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","volume":"34","author":"FA van Nimwegen","year":"2016","unstructured":"van Nimwegen, F. A. et al. Radiation dose\u2013response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J. Clin. Oncol. 34, 235\u2013243 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR79","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1200\/JCO.2007.15.1001","volume":"26","author":"BA Campbell","year":"2008","unstructured":"Campbell, B. A. et al. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin\u2019s lymphoma: a question of field size. J. Clin. Oncol. 26, 5170\u20135174 (2008).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-2-13","volume":"2","author":"ES Koh","year":"2007","unstructured":"Koh, E. S. et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin\u2019s lymphoma: reduction in normal tissue dose and second cancer risk. Radiat. Oncol. 2, 13 (2007).","journal-title":"Radiat. Oncol."},{"key":"1056_CR81","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1007\/s12094-022-03034-z","volume":"25","author":"OA Houlihan","year":"2023","unstructured":"Houlihan, O. A. et al. Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma. Clin. Transl. Oncol. 25, 1368\u20131377 (2023).","journal-title":"Clin. Transl. Oncol."},{"key":"1056_CR82","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00066-020-01721-w","volume":"197","author":"AY Lundgaard","year":"2021","unstructured":"Lundgaard, A. Y. et al. The risk of late effects following pediatric and adult radiotherapy regimens in Hodgkin lymphoma. Strahlenther. Onkol. 197, 711\u2013721 (2021).","journal-title":"Strahlenther. Onkol."},{"key":"1056_CR83","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.radonc.2011.08.040","volume":"101","author":"L Cella","year":"2011","unstructured":"Cella, L. et al. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin\u2019s lymphoma. Radiother. Oncol. 101, 316\u2013321 (2011).","journal-title":"Radiother. Oncol."},{"key":"1056_CR84","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","volume":"83","author":"MV Maraldo","year":"2012","unstructured":"Maraldo, M. V. et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 83, 1232\u20131237 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR85","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","volume":"13","author":"TA Moo","year":"2018","unstructured":"Moo, T. A., Sanford, R., Dang, C. & Morrow, M. Overview of breast cancer therapy. PET Clin. 13, 339\u2013354 (2018).","journal-title":"PET Clin."},{"key":"1056_CR86","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.breast.2023.03.009","volume":"69","author":"M Dzhugashvili","year":"2023","unstructured":"Dzhugashvili, M., Veldeman, L. & Kirby, A. M. The role of the radiation therapy breast boost in the 2020s. Breast 69, 299\u2013305 (2023).","journal-title":"Breast"},{"key":"1056_CR87","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ijrobp.2005.10.022","volume":"64","author":"MJ Hooning","year":"2006","unstructured":"Hooning, M. J. et al. Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int. J. Radiat. Oncol. Biol. Phys. 64, 1081\u20131091 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR88","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","volume":"24","author":"EE Harris","year":"2006","unstructured":"Harris, E. E. et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J. Clin. Oncol. 24, 4100\u20134106 (2006).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR89","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","volume":"6","author":"SC Darby","year":"2005","unstructured":"Darby, S. C., McGale, P., Taylor, C. W. & Peto, R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 6, 557\u2013565 (2005).","journal-title":"Lancet Oncol."},{"key":"1056_CR90","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","volume":"25","author":"CR Correa","year":"2007","unstructured":"Correa, C. R. et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J. Clin. Oncol. 25, 3031\u20133037 (2007).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR91","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby, S. C. et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368, 987\u2013998 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1056_CR92","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.radonc.2017.10.009","volume":"126","author":"CTG Roos","year":"2018","unstructured":"Roos, C. T. G. et al. Is the coronary artery calcium score associated with acute coronary events in breast cancer patients treated with radiotherapy? Radiother. Oncol. 126, 170\u2013176 (2018).","journal-title":"Radiother. Oncol."},{"key":"1056_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2020.08.007","volume":"152","author":"E Laugaard Lorenzen","year":"2020","unstructured":"Laugaard Lorenzen, E., Christian Rehammar, J., Jensen, M. B., Ewertz, M. & Brink, C. Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977\u20132005. Radiother. Oncol. 152, 103\u2013110 (2020).","journal-title":"Radiother. Oncol."},{"key":"1056_CR94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.breast.2022.07.003","volume":"65","author":"K Kim","year":"2022","unstructured":"Kim, K. et al. Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy. Breast 65, 77\u201383 (2022).","journal-title":"Breast"},{"key":"1056_CR95","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","volume":"35","author":"VA van den Bogaard","year":"2017","unstructured":"van den Bogaard, V. A. et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J. Clin. Oncol. 35, 1171\u20131178 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR96","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/ejhf.1620","volume":"22","author":"NB Boekel","year":"2020","unstructured":"Boekel, N. B. et al. Heart failure after treatment for breast cancer. Eur. J. Heart Fail. 22, 366\u2013374 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"1056_CR97","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2022.04.019","volume":"114","author":"AH Zureick","year":"2022","unstructured":"Zureick, A. H. et al. Dose to the left anterior descending artery correlates with cardiac events after irradiation for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 114, 130\u2013139 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR98","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1161\/CIRCULATIONAHA.116.025434","volume":"135","author":"H Saiki","year":"2017","unstructured":"Saiki, H. et al. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation 135, 1388\u20131396 (2017).","journal-title":"Circulation"},{"key":"1056_CR99","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41416-018-0159-x","volume":"119","author":"NB Boekel","year":"2018","unstructured":"Boekel, N. B. et al. Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer. Br. J. Cancer 119, 408\u2013418 (2018).","journal-title":"Br. J. Cancer"},{"key":"1056_CR100","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2478\/raon-2013-0040","volume":"48","author":"T Marinko","year":"2014","unstructured":"Marinko, T., Dolenc, J. & Bilban-Jakopin, C. Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer. Radiol. Oncol. 48, 105\u2013112 (2014).","journal-title":"Radiol. Oncol."},{"key":"1056_CR101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijrobp.2014.06.030","volume":"90","author":"CE Rutter","year":"2014","unstructured":"Rutter, C. E., Chagpar, A. B. & Evans, S. B. Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality. Int. J. Radiat. Oncol. Biol. Phys. 90, 329\u2013334 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR102","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10549-021-06412-3","volume":"191","author":"H Merzenich","year":"2022","unstructured":"Merzenich, H. et al. Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa). Breast Cancer Res. Treat. 191, 147\u2013157 (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"1056_CR103","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.2147\/CMAR.S172595","volume":"10","author":"WH Li","year":"2018","unstructured":"Li, W. H. et al. No association between tumor laterality and cardiac-related mortality in breast cancer patients after radiotherapy: a population-based study. Cancer Manag. Res. 10, 3649\u20133656 (2018).","journal-title":"Cancer Manag. Res."},{"key":"1056_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2022.05.007","volume":"65","author":"D Baaken","year":"2022","unstructured":"Baaken, D. et al. A nested case\u2013control study on radiation dose\u2013response for cardiac events in breast cancer patients in Germany. Breast 65, 1\u20137 (2022).","journal-title":"Breast"},{"key":"1056_CR105","unstructured":"Cancer Epidemiology and Prevention 4th edn (Oxford Univ. Press, 2017)."},{"key":"1056_CR106","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.rpor.2020.02.005","volume":"25","author":"M Vosmik","year":"2020","unstructured":"Vosmik, M. et al. Cardiotoxicity of radiation therapy in esophageal cancer. Rep. Pract. Oncol. Radiother. 25, 318\u2013322 (2020).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"1056_CR107","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.JTO.0000437420.38972.fb","volume":"8","author":"F Lou","year":"2013","unstructured":"Lou, F. et al. Esophageal cancer recurrence patterns and implications for surveillance. J. Thorac. Oncol. 8, 1558\u20131562 (2013).","journal-title":"J. Thorac. Oncol."},{"key":"1056_CR108","doi-asserted-by":"publisher","first-page":"976711","DOI":"10.3389\/fonc.2022.976711","volume":"12","author":"Y Xia","year":"2022","unstructured":"Xia, Y., Lin, M., Huang, J. & Fan, L. Cardiovascular disease related death among patients with esophagus cancer: a population-based competing risk analysis. Front. Oncol. 12, 976711 (2022).","journal-title":"Front. Oncol."},{"key":"1056_CR109","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","volume":"70","author":"X Wei","year":"2008","unstructured":"Wei, X. et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 707\u2013714 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR110","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ijrobp.2010.03.046","volume":"80","author":"K Shirai","year":"2011","unstructured":"Shirai, K. et al. Dose\u2013volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 80, 1002\u20131007 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR111","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.radonc.2012.04.016","volume":"104","author":"A Konski","year":"2012","unstructured":"Konski, A. et al. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother. Oncol. 104, 72\u201377 (2012).","journal-title":"Radiother. Oncol."},{"key":"1056_CR112","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2023.08.011","volume":"118","author":"ED Miller","year":"2024","unstructured":"Miller, E. D. et al. Incident atrial fibrillation and survival outcomes in esophageal cancer following radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 118, 124\u2013136 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR113","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00066-017-1127-8","volume":"193","author":"I Ogino","year":"2017","unstructured":"Ogino, I. et al. Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer. Strahlenther. Onkol. 193, 552\u2013560 (2017).","journal-title":"Strahlenther. Onkol."},{"key":"1056_CR114","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J. Thorac. Oncol. 15, 1682\u20131690 (2020).","journal-title":"J. Thorac. Oncol."},{"key":"1056_CR115","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fonc.2020.00153","volume":"10","author":"G Cai","year":"2020","unstructured":"Cai, G., Li, C., Yu, J. & Meng, X. Heart dosimetric parameters were associated with cardiac events and overall survival for patients with locally advanced esophageal cancer receiving definitive radiotherapy. Front. Oncol. 10, 153 (2020).","journal-title":"Front. Oncol."},{"key":"1056_CR116","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.21037\/jtd-2019-cptn-06","volume":"12","author":"KR Gergelis","year":"2020","unstructured":"Gergelis, K. R. et al. Proton beam radiotherapy for esophagus cancer: state of the art. J. Thorac. Dis. 12, 7002\u20137010 (2020).","journal-title":"J. Thorac. Dis."},{"key":"1056_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-016-0693-8","volume":"11","author":"S Baker","year":"2016","unstructured":"Baker, S., Dahele, M., Lagerwaard, F. J. & Senan, S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat. Oncol. 11, 115 (2016).","journal-title":"Radiat. Oncol."},{"key":"1056_CR118","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley, J. D. et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 16, 187\u2013199 (2015).","journal-title":"Lancet Oncol."},{"key":"1056_CR119","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang, K. et al. Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J. Clin. Oncol. 35, 1387\u20131394 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR120","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jtho.2023.01.085","volume":"18","author":"A McWilliam","year":"2023","unstructured":"McWilliam, A., Abravan, A., Banfill, K., Faivre-Finn, C. & van Herk, M. Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival. J. Thorac. Oncol. 18, 599\u2013607 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"1056_CR121","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","volume":"5","author":"HJ No","year":"2023","unstructured":"No, H. J. et al. Predicting adverse cardiac events after radiotherapy for locally advanced non-small cell lung cancer. JACC CardioOncol. 5, 775\u2013787 (2023).","journal-title":"JACC CardioOncol."},{"key":"1056_CR122","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","volume":"8","author":"KH Kim","year":"2022","unstructured":"Kim, K. H. et al. Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer. JAMA Oncol. 8, 1624\u20131634 (2022).","journal-title":"JAMA Oncol."},{"key":"1056_CR123","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.lungcan.2018.03.024","volume":"120","author":"CC Lee","year":"2018","unstructured":"Lee, C. C. et al. Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy. Lung Cancer 120, 54\u201359 (2018).","journal-title":"Lung Cancer"},{"key":"1056_CR124","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","volume":"13","author":"N Yegya-Raman","year":"2018","unstructured":"Yegya-Raman, N. et al. Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC. J. Thorac. Oncol. 13, 1508\u20131518 (2018).","journal-title":"J. Thorac. Oncol."},{"key":"1056_CR125","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","volume":"73","author":"M Atkins Katelyn","year":"2019","unstructured":"Atkins Katelyn, M. et al. Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer. J. Am. Coll. Cardiol. 73, 2976\u20132987 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1056_CR126","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","volume":"7","author":"KM Atkins","year":"2021","unstructured":"Atkins, K. M. et al. Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer. JAMA Oncol. 7, 206\u2013219 (2021).","journal-title":"JAMA Oncol."},{"key":"1056_CR127","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s12149-022-01724-w","volume":"36","author":"SG Cho","year":"2022","unstructured":"Cho, S. G. et al. Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET. Ann. Nucl. Med. 36, 439\u2013449 (2022).","journal-title":"Ann. Nucl. Med."},{"key":"1056_CR128","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ultrasmedbio.2018.09.012","volume":"45","author":"L Chen","year":"2019","unstructured":"Chen, L., Ta, S., Wu, W., Wang, C. & Zhang, Q. Prognostic and added value of echocardiographic strain for prediction of adverse outcomes in patients with locally advanced non-small cell lung cancer after radiotherapy. Ultrasound Med. Biol. 45, 98\u2013107 (2019).","journal-title":"Ultrasound Med. Biol."},{"key":"1056_CR129","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.21037\/jtd.2019.06.29","volume":"11","author":"L Ni","year":"2019","unstructured":"Ni, L. et al. Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation. J. Thorac. Dis. 11, 2229\u20132239 (2019).","journal-title":"J. Thorac. Dis."},{"key":"1056_CR130","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","volume":"35","author":"RT Dess","year":"2017","unstructured":"Dess, R. T. et al. Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer. J. Clin. Oncol. 35, 1395\u20131402 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR131","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","volume":"20","author":"JF Borkenhagen","year":"2019","unstructured":"Borkenhagen, J. F. et al. Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer. Clin. Lung Cancer 20, 435\u2013441 (2019).","journal-title":"Clin. Lung Cancer"},{"key":"1056_CR132","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jaccao.2021.06.007","volume":"3","author":"C Bergom","year":"2021","unstructured":"Bergom, C. et al. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC CardioOncol 3, 343\u2013359 (2021).","journal-title":"JACC CardioOncol"},{"key":"1056_CR133","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","volume":"92","author":"AR Filippi","year":"2015","unstructured":"Filippi, A. R. et al. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk. Int. J. Radiat. Oncol. Biol. Phys. 92, 161\u2013168 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR134","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","volume":"24","author":"MV Maraldo","year":"2013","unstructured":"Maraldo, M. V. et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann. Oncol. 24, 2113\u20132118 (2013).","journal-title":"Ann. Oncol."},{"key":"1056_CR135","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hed.23280","volume":"36","author":"JA Dorth","year":"2014","unstructured":"Dorth, J. A., Patel, P. R., Broadwater, G. & Brizel, D. M. Incidence and risk factors of significant carotid artery stenosis in asymptomatic survivors of head and neck cancer after radiotherapy. Head Neck 36, 215\u2013219 (2014).","journal-title":"Head Neck"},{"key":"1056_CR136","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","volume":"35","author":"SG Chun","year":"2017","unstructured":"Chun, S. G. et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial. J. Clin. Oncol. 35, 56\u201362 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR137","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ijrobp.2018.10.025","volume":"103","author":"JN Jacobse","year":"2019","unstructured":"Jacobse, J. N. et al. Radiation dose\u2013response for risk of myocardial infarction in breast cancer survivors. Int. J. Radiat. Oncol. Biol. Phys. 103, 595\u2013604 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR138","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2021.03.004","volume":"110","author":"VAB van den Bogaard","year":"2021","unstructured":"van den Bogaard, V. A. B. et al. The importance of radiation dose to the atherosclerotic plaque in the left anterior descending coronary artery for radiation-induced cardiac toxicity of breast cancer patients? Int. J. Radiat. Oncol. Biol. Phys. 110, 1350\u20131359 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR139","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.prro.2019.09.015","volume":"10","author":"BS Hoppe","year":"2020","unstructured":"Hoppe, B. S. et al. The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era. Pract. Radiat. Oncol. 10, e147\u2013e154 (2020).","journal-title":"Pract. Radiat. Oncol."},{"key":"1056_CR140","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1200\/JCO.2017.77.6351","volume":"36","author":"C Taylor","year":"2018","unstructured":"Taylor, C. et al. Cardiac structure injury after radiotherapy for breast cancer: cross-sectional study with individual patient data. J. Clin. Oncol. 36, 2288\u20132296 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR141","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2022.02.010","volume":"169","author":"MC Tjong","year":"2022","unstructured":"Tjong, M. C. et al. Major adverse cardiac event risk prediction model incorporating baseline cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose in lung cancer (CHyLL). Radiother. Oncol. 169, 105\u2013113 (2022).","journal-title":"Radiother. Oncol."},{"key":"1056_CR142","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/0284186X.2016.1182209","volume":"55","author":"G Nilsson","year":"2016","unstructured":"Nilsson, G. et al. Radiation dose distribution in coronary arteries in breast cancer radiotherapy. Acta Oncol. 55, 959\u2013963 (2016).","journal-title":"Acta Oncol."},{"key":"1056_CR143","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijrobp.2007.12.058","volume":"72","author":"CW Taylor","year":"2008","unstructured":"Taylor, C. W. et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int. J. Radiat. Oncol. Biol. Phys. 72, 501\u2013507 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR144","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjcard.2020.12.038","volume":"143","author":"T Tagami","year":"2021","unstructured":"Tagami, T. et al. Usefulness of coronary computed tomographic angiography to evaluate coronary artery disease in radiotherapy-treated breast cancer survivors. Am. J. Cardiol. 143, 14\u201320 (2021).","journal-title":"Am. J. Cardiol."},{"key":"1056_CR145","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","volume":"30","author":"G Nilsson","year":"2012","unstructured":"Nilsson, G. et al. Distribution of coronary artery stenosis after radiation for breast cancer. J. Clin. Oncol. 30, 380\u2013386 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-019-1242-z","volume":"14","author":"AK Wennstig","year":"2019","unstructured":"Wennstig, A. K. et al. The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors. Radiat. Oncol. 14, 40 (2019).","journal-title":"Radiat. Oncol."},{"key":"1056_CR147","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijrobp.2014.01.021","volume":"89","author":"T Girinsky","year":"2014","unstructured":"Girinsky, T. et al. Prospective coronary heart disease screening in asymptomatic Hodgkin lymphoma patients using coronary computed tomography angiography: results and risk factor analysis. Int. J. Radiat. Oncol. Biol. Phys. 89, 59\u201366 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR148","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.radonc.2015.07.043","volume":"117","author":"A Moignier","year":"2015","unstructured":"Moignier, A. et al. Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation. Radiother. Oncol. 117, 467\u2013472 (2015).","journal-title":"Radiother. Oncol."},{"key":"1056_CR149","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00095","volume":"6","author":"KM Atkins","year":"2022","unstructured":"Atkins, K. M. et al. Elevated coronary artery calcium quantified by a validated deep learning model from lung cancer radiotherapy planning scans predicts mortality. JCO Clin. Cancer Inf. 6, e2100095 (2022).","journal-title":"JCO Clin. Cancer Inf."},{"key":"1056_CR150","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1148\/101.2.429","volume":"101","author":"LF Fajardo","year":"1971","unstructured":"Fajardo, L. F. & Stewart, J. R. Capillary injury preceding radiation-induced myocardial fibrosis. Radiology 101, 429\u2013433 (1971).","journal-title":"Radiology"},{"key":"1056_CR151","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02841860510007440","volume":"44","author":"LF Fajardo","year":"2005","unstructured":"Fajardo, L. F. The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol. 44, 13\u201322 (2005).","journal-title":"Acta Oncol."},{"key":"1056_CR152","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jacc.2009.10.047","volume":"55","author":"M Halle","year":"2010","unstructured":"Halle, M. et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J. Am. Coll. Cardiol. 55, 1227\u20131236 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1056_CR153","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","volume":"3","author":"BP Venkatesulu","year":"2018","unstructured":"Venkatesulu, B. P. et al. Radiation-induced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl. Sci. 3, 563\u2013572 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"1056_CR154","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/heartjnl-2015-308765","volume":"102","author":"DM Gujral","year":"2016","unstructured":"Gujral, D. M., Lloyd, G. & Bhattacharyya, S. Radiation-induced valvular heart disease. Heart 102, 269\u2013276 (2016).","journal-title":"Heart"},{"key":"1056_CR155","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","volume":"84","author":"BS Hoppe","year":"2012","unstructured":"Hoppe, B. S. et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 84, 449\u2013455 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR156","doi-asserted-by":"publisher","first-page":"djv008","DOI":"10.1093\/jnci\/djv008","volume":"107","author":"DJ Cutter","year":"2015","unstructured":"Cutter, D. J. et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J. Natl Cancer Inst. 107, djv008 (2015).","journal-title":"J. Natl Cancer Inst."},{"key":"1056_CR157","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.jtcvs.2012.08.041","volume":"144","author":"NA Nadlonek","year":"2012","unstructured":"Nadlonek, N. A. et al. Radiation induces osteogenesis in human aortic valve interstitial cells. J. Thorac. Cardiovasc. Surg. 144, 1466\u20131470 (2012).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1056_CR158","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.3390\/jcm12185854","volume":"12","author":"G Rucher","year":"2023","unstructured":"Rucher, G. et al. Targeted radiation exposure induces accelerated aortic valve remodeling in ApoE(\u2212\/\u2212) mice. J. Clin. Med. 12, 5854 (2023).","journal-title":"J. Clin. Med."},{"key":"1056_CR159","doi-asserted-by":"publisher","first-page":"892882","DOI":"10.3389\/fonc.2022.892882","volume":"12","author":"MY Errahmani","year":"2022","unstructured":"Errahmani, M. Y. et al. Association between cardiac radiation exposure and the risk of arrhythmia in breast cancer patients treated with radiotherapy: a case\u2013control study. Front. Oncol. 12, 892882 (2022).","journal-title":"Front. Oncol."},{"key":"1056_CR160","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/0284186X.2021.2025265","volume":"61","author":"P Loap","year":"2022","unstructured":"Loap, P. et al. Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation. Acta Oncol. 61, 496\u2013499 (2022).","journal-title":"Acta Oncol."},{"key":"1056_CR161","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","volume":"99","author":"JY Chang","year":"2017","unstructured":"Chang, J. Y. et al. Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG Thoracic and Lymphoma Subcommittee. Int. J. Radiat. Oncol. Biol. Phys. 99, 41\u201350 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR162","first-page":"100936","volume":"38","author":"MY Errahmani","year":"2022","unstructured":"Errahmani, M. Y. et al. Risk of pacemaker implantation after radiotherapy for breast cancer: a study based on French nationwide health care database sample. Int. J. Cardiol. Heart Vasc. 38, 100936 (2022).","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"1056_CR163","first-page":"62","volume":"38","author":"MY Errahmani","year":"2023","unstructured":"Errahmani, M. Y. et al. Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses. Clin. Transl. Radiat. Oncol. 38, 62\u201370 (2023).","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"1056_CR164","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/HP.0000000000000817","volume":"115","author":"BV Becker","year":"2018","unstructured":"Becker, B. V. et al. Impact of ionizing radiation on electrophysiological behavior of human-induced iPSC-derived cardiomyocytes on multielectrode arrays. Health Phys. 115, 21\u201328 (2018).","journal-title":"Health Phys."},{"key":"1056_CR165","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3390\/cells10102608","volume":"10","author":"T Smit","year":"2021","unstructured":"Smit, T. et al. A human 3D cardiomyocyte risk model to study the cardiotoxic influence of X-rays and other noxae in adults. Cells 10, 2608 (2021).","journal-title":"Cells"},{"key":"1056_CR166","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0360-3016(91)90794-5","volume":"21","author":"JM Cosset","year":"1991","unstructured":"Cosset, J. M. et al. Pericarditis and myocardial infarctions after Hodgkin\u2019s disease therapy. Int. J. Radiat. Oncol. Biol. Phys. 21, 447\u2013449 (1991).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR167","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11886-019-1192-y","volume":"21","author":"N Szpakowski","year":"2019","unstructured":"Szpakowski, N. & Desai, M. Y. Radiation-associated pericardial disease. Curr. Cardiol. Rep. 21, 97 (2019).","journal-title":"Curr. Cardiol. Rep."},{"key":"1056_CR168","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.radonc.2018.10.029","volume":"133","author":"J Xue","year":"2019","unstructured":"Xue, J. et al. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer. Radiother. Oncol. 133, 213\u2013219 (2019).","journal-title":"Radiother. Oncol."},{"key":"1056_CR169","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijrobp.2013.07.008","volume":"87","author":"J Fukada","year":"2013","unstructured":"Fukada, J. et al. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 87, 487\u2013493 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR170","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005932","volume":"96","author":"XF Zhuang","year":"2017","unstructured":"Zhuang, X. F., Yang, Y. M., Sun, X. L., Liao, Z. K. & Huang, J. Late onset radiation-induced constrictive pericarditis and cardiomyopathy after radiotherapy: a case report. Medicine 96, e5932 (2017).","journal-title":"Medicine"},{"key":"1056_CR171","doi-asserted-by":"publisher","first-page":"411","DOI":"10.14503\/THIJ-16-6054","volume":"44","author":"BT Yeneneh","year":"2017","unstructured":"Yeneneh, B. T., Allen, S., Panse, P., Mookadam, F. & Rule, W. Constrictive pericarditis 5 months after radiation therapy in a 62-year-old woman with esophageal cancer. Tex. Heart Inst. J. 44, 411\u2013415 (2017).","journal-title":"Tex. Heart Inst. J."},{"key":"1056_CR172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.radonc.2022.04.030","volume":"173","author":"GM Walls","year":"2022","unstructured":"Walls, G. M. et al. Murine models of radiation cardiotoxicity: a systematic review and recommendations for future studies. Radiother. Oncol. 173, 19\u201331 (2022).","journal-title":"Radiother. Oncol."},{"key":"1056_CR173","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1080\/09553002.2023.2194404","volume":"99","author":"N Andruska","year":"2023","unstructured":"Andruska, N. et al. Differences in radiation-induced heart dysfunction in male versus female rats. Int. J. Radiat. Biol. 99, 1096\u20131108 (2023).","journal-title":"Int. J. Radiat. Biol."},{"key":"1056_CR174","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/cancers15020406","volume":"15","author":"V Sridharan","year":"2023","unstructured":"Sridharan, V. et al. Effects of whole and partial heart irradiation on collagen, mast cells, and toll-like receptor 4 in the mouse heart. Cancers 15, 406 (2023).","journal-title":"Cancers"},{"key":"1056_CR175","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ijrobp.2018.02.017","volume":"101","author":"W Sievert","year":"2018","unstructured":"Sievert, W., Stangl, S., Steiger, K. & Multhoff, G. Improved overall survival of mice by reducing lung side effects after high-precision heart irradiation using a small animal radiation research platform. Int. J. Radiat. Oncol. Biol. Phys. 101, 671\u2013679 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR176","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","volume":"42","author":"PA Heidenreich","year":"2003","unstructured":"Heidenreich, P. A., Hancock, S. L., Lee, B. K., Mariscal, C. S. & Schnittger, I. Asymptomatic cardiac disease following mediastinal irradiation. J. Am. Coll. Cardiol. 42, 743\u2013749 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1056_CR177","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.ahj.2004.12.026","volume":"150","author":"PA Heidenreich","year":"2005","unstructured":"Heidenreich, P. A., Hancock, S. L., Vagelos, R. H., Lee, B. K. & Schnittger, I. Diastolic dysfunction after mediastinal irradiation. Am. Heart J. 150, 977\u2013982 (2005).","journal-title":"Am. Heart J."},{"key":"1056_CR178","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.crad.2014.08.010","volume":"69","author":"R Umezawa","year":"2014","unstructured":"Umezawa, R. et al. MRI findings of radiation-induced myocardial damage in patients with oesophageal cancer. Clin. Radiol. 69, 1273\u20131279 (2014).","journal-title":"Clin. Radiol."},{"key":"1056_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02319-z","volume":"18","author":"M Moisander","year":"2023","unstructured":"Moisander, M. et al. Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients \u2014 multimodality imaging study with six-year follow-up. Radiat. Oncol. 18, 124 (2023).","journal-title":"Radiat. Oncol."},{"key":"1056_CR180","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus, W. J. & Zile, M. R. From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited. Circ. Res. 128, 1451\u20131467 (2021).","journal-title":"Circ. Res."},{"key":"1056_CR181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068922","volume":"8","author":"I Seemann","year":"2013","unstructured":"Seemann, I., Te Poele, J. A., Luikinga, S. J., Hoving, S. & Stewart, F. A. Endoglin haplo-insufficiency modifies the inflammatory response in irradiated mouse hearts without affecting structural and mircovascular changes. PLoS ONE 8, e68922 (2013).","journal-title":"PLoS ONE"},{"key":"1056_CR182","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00066-014-0745-7","volume":"191","author":"I Patties","year":"2015","unstructured":"Patties, I., Haagen, J., Dorr, W., Hildebrandt, G. & Glasow, A. Late inflammatory and thrombotic changes in irradiated hearts of C57BL\/6 wild-type and atherosclerosis-prone ApoE-deficient mice. Strahlenther. Onkol. 191, 172\u2013179 (2015).","journal-title":"Strahlenther. Onkol."},{"key":"1056_CR183","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1021\/pr400071g","volume":"12","author":"O Azimzadeh","year":"2013","unstructured":"Azimzadeh, O. et al. PPAR alpha: a novel radiation target in locally exposed Mus musculus heart revealed by quantitative proteomics. J. Proteome Res. 12, 2700\u20132714 (2013).","journal-title":"J. Proteome Res."},{"key":"1056_CR184","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.3390\/ijms20205239","volume":"20","author":"Z Barjaktarovic","year":"2019","unstructured":"Barjaktarovic, Z. et al. Hyperacetylation of cardiac mitochondrial proteins is associated with metabolic impairment and sirtuin downregulation after chronic total body irradiation of ApoE(\u2212\/\u2212) mice. Int. J. Mol. Sci. 20, 5239 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1056_CR185","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.18632\/oncotarget.10424","volume":"8","author":"O Azimzadeh","year":"2017","unstructured":"Azimzadeh, O. et al. A dose-dependent perturbation in cardiac energy metabolism is linked to radiation-induced ischemic heart disease in Mayak nuclear workers. Oncotarget 8, 9067\u20139078 (2017).","journal-title":"Oncotarget"},{"key":"1056_CR186","doi-asserted-by":"publisher","first-page":"H1267","DOI":"10.1152\/ajpheart.00482.2018","volume":"316","author":"RA Schlaak","year":"2019","unstructured":"Schlaak, R. A. et al. Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3. Am. J. Physiol. Heart Circ. Physiol. 316, H1267\u2013H1280 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1056_CR187","first-page":"1","volume":"42","author":"ICRP","year":"2013","unstructured":"ICRP et al. ICRP publication 121: radiological protection in paediatric diagnostic and interventional radiology. Ann. ICRP 42, 1\u201363 (2013).","journal-title":"Ann. ICRP"},{"key":"1056_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1667\/RR0763.1","volume":"168","author":"DL Preston","year":"2007","unstructured":"Preston, D. L. et al. Solid cancer incidence in atomic bomb survivors: 1958\u20131998. Radiat. Res. 168, 1\u201364 (2007).","journal-title":"Radiat. Res."},{"key":"1056_CR189","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0360-3016(96)00295-7","volume":"36","author":"V King","year":"1996","unstructured":"King, V. et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin\u2019s disease. Int. J. Radiat. Oncol. Biol. Phys. 36, 881\u2013889 (1996).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR190","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1200\/JCO.1998.16.8.2625","volume":"16","author":"LF Paszat","year":"1998","unstructured":"Paszat, L. F. et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J. Clin. Oncol. 16, 2625\u20132631 (1998).","journal-title":"J. Clin. Oncol."},{"key":"1056_CR191","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1667\/RR15043.1","volume":"192","author":"M Lenarczyk","year":"2019","unstructured":"Lenarczyk, M. et al. Age at exposure to radiation determines severity of renal and cardiac disease in rats. Radiat. Res. 192, 63\u201374 (2019).","journal-title":"Radiat. Res."},{"key":"1056_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10271-3","volume":"12","author":"B Langen","year":"2022","unstructured":"Langen, B. et al. Age and sex effects across the blood proteome after ionizing radiation exposure can bias biomarker screening and risk assessment. Sci. Rep. 12, 7000 (2022).","journal-title":"Sci. Rep."},{"key":"1056_CR193","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1667\/RR2176.1","volume":"175","author":"RE Mitchel","year":"2011","unstructured":"Mitchel, R. E. et al. Low-dose radiation exposure and atherosclerosis in ApoE\u2212\/\u2212 mice. Radiat. Res. 175, 665\u2013676 (2011).","journal-title":"mice. Radiat. Res."},{"key":"1056_CR194","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11886-022-01724-2","volume":"24","author":"B Haring","year":"2022","unstructured":"Haring, B., Wissel, S. & Manson, J. E. Somatic mutations and clonal hematopoiesis as drivers of age-related cardiovascular risk. Curr. Cardiol. Rep. 24, 1049\u20131058 (2022).","journal-title":"Curr. Cardiol. Rep."},{"key":"1056_CR195","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jat.3088","volume":"35","author":"Y Hirabayashi","year":"2015","unstructured":"Hirabayashi, Y., Tsuboi, I., Nakachi, K., Kusunoki, Y. & Inoue, T. Experimentally induced, synergistic late effects of a single dose of radiation and aging: significance in LKS fraction as compared with mature blood cells. J. Appl. Toxicol. 35, 230\u2013240 (2015).","journal-title":"J. Appl. Toxicol."},{"key":"1056_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21621-6","volume":"12","author":"K Yoshida","year":"2022","unstructured":"Yoshida, K. et al. Massive expansion of multiple clones in the mouse hematopoietic system long after whole-body X-irradiation. Sci. Rep. 12, 17276 (2022).","journal-title":"Sci. Rep."},{"key":"1056_CR197","doi-asserted-by":"publisher","first-page":"108458","DOI":"10.1016\/j.celrep.2020.108458","volume":"33","author":"N Mencia-Trinchant","year":"2020","unstructured":"Mencia-Trinchant, N. et al. Clonal hematopoiesis before, during, and after human spaceflight. Cell Rep. 33, 108458 (2020).","journal-title":"Cell Rep."},{"key":"1056_CR198","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208055","volume":"102","author":"KM Anthony","year":"2024","unstructured":"Anthony, K. M. et al. Radon exposure, clonal hematopoiesis, and stroke susceptibility in the Women\u2019s Health Initiative. Neurology 102, e208055 (2024).","journal-title":"Neurology"},{"key":"1056_CR199","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1530\/REP-18-0089","volume":"155","author":"BF Kimler","year":"2018","unstructured":"Kimler, B. F. et al. Radiation-induced ovarian follicle loss occurs without overt stromal changes. Reproduction 155, 553\u2013562 (2018).","journal-title":"Reproduction"},{"key":"1056_CR200","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fgene.2019.00260","volume":"10","author":"N Narendran","year":"2019","unstructured":"Narendran, N., Luzhna, L. & Kovalchuk, O. Sex difference of radiation response in occupational and accidental exposure. Front. Genet. 10, 260 (2019).","journal-title":"Front. Genet."},{"key":"1056_CR201","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/ijms19030713","volume":"19","author":"C Rong","year":"2018","unstructured":"Rong, C., Meinert, E. & Hess, J. Estrogen receptor signaling in radiotherapy: from molecular mechanisms to clinical studies. Int. J. Mol. Sci. 19, 713 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1056_CR202","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1158\/0008-5472.CAN-15-0892","volume":"75","author":"DE Spratt","year":"2015","unstructured":"Spratt, D. E. et al. Androgen receptor upregulation mediates radioresistance after ionizing radiation. Cancer Res. 75, 4688\u20134696 (2015).","journal-title":"Cancer Res."},{"key":"1056_CR203","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrendo.2017.12","volume":"13","author":"E Morselli","year":"2017","unstructured":"Morselli, E. et al. The effects of oestrogens and their receptors on cardiometabolic health. Nat. Rev. Endocrinol. 13, 352\u2013364 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1056_CR204","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.3390\/cancers13163973","volume":"13","author":"N Chmielewski-Stivers","year":"2021","unstructured":"Chmielewski-Stivers, N. et al. Sex-specific differences in toxicity following systemic paclitaxel treatment and localized cardiac radiotherapy. Cancers 13, 3973 (2021).","journal-title":"Cancers"},{"key":"1056_CR205","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3892\/mmr.2021.12038","volume":"23","author":"R Ramadan","year":"2021","unstructured":"Ramadan, R. et al. X-irradiation induces acute and early term inflammatory responses in atherosclerosis-prone ApoE\u2212\/\u2212 mice and in endothelial cells. Mol. Med. Rep. 23, 399 (2021).","journal-title":"Mol. Med. Rep."},{"key":"1056_CR206","first-page":"12","volume":"6","author":"Y Khalid","year":"2020","unstructured":"Khalid, Y. et al. Gender disparity in cardiovascular mortality following radiation therapy for Hodgkin\u2019s lymphoma: a systematic review. Cardiooncology 6, 12 (2020).","journal-title":"Cardiooncology"},{"key":"1056_CR207","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2307\/3577520","volume":"119","author":"TK Yeung","year":"1989","unstructured":"Yeung, T. K., Lauk, S., Simmonds, R. H., Hopewell, J. W. & Trott, K. R. Morphological and functional changes in the rat heart after X irradiation: strain differences. Radiat. Res. 119, 489\u2013499 (1989).","journal-title":"Radiat. Res."},{"key":"1056_CR208","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fonc.2012.00094","volume":"2","author":"CK Haston","year":"2012","unstructured":"Haston, C. K. Mouse genetic approaches applied to the normal tissue radiation response. Front. Oncol. 2, 94 (2012).","journal-title":"Front. Oncol."},{"key":"1056_CR209","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1053-4296(05)80034-7","volume":"4","author":"SM Bentzen","year":"1994","unstructured":"Bentzen, S. M. & Overgaard, J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin. Radiat. Oncol. 4, 68\u201380 (1994).","journal-title":"Semin. Radiat. Oncol."},{"key":"1056_CR210","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","volume":"135","author":"P Natarajan","year":"2017","unstructured":"Natarajan, P. et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation 135, 2091\u20132101 (2017).","journal-title":"Circulation"},{"key":"1056_CR211","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/02841860152619115","volume":"40","author":"RA Gatti","year":"2001","unstructured":"Gatti, R. A. The inherited basis of human radiosensitivity. Acta Oncol. 40, 702\u2013711 (2001).","journal-title":"Acta Oncol."},{"key":"1056_CR212","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nature02797","volume":"430","author":"M Morley","year":"2004","unstructured":"Morley, M. et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743\u2013747 (2004).","journal-title":"Nature"},{"key":"1056_CR213","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.semradonc.2017.04.005","volume":"27","author":"BS Rosenstein","year":"2017","unstructured":"Rosenstein, B. S. Radiogenomics: identification of genomic predictors for radiation toxicity. Semin. Radiat. Oncol. 27, 300\u2013309 (2017).","journal-title":"Semin. Radiat. Oncol."},{"key":"1056_CR214","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ijrobp.2022.06.098","volume":"114","author":"GC Barnett","year":"2022","unstructured":"Barnett, G. C. et al. No association between polygenic risk scores for cancer and development of radiation therapy toxicity. Int. J. Radiat. Oncol. Biol. Phys. 114, 494\u2013501 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR215","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.cell.2020.10.050","volume":"183","author":"E Afshinnekoo","year":"2020","unstructured":"Afshinnekoo, E. et al. Fundamental biological features of spaceflight: advancing the field to enable deep-space exploration. Cell 183, 1162\u20131184 (2020).","journal-title":"Cell"},{"key":"1056_CR216","doi-asserted-by":"publisher","first-page":"20200217","DOI":"10.1259\/bjr.20200217","volume":"93","author":"RJ Griffin","year":"2020","unstructured":"Griffin, R. J. et al. History and current perspectives on the biological effects of high-dose spatial fractionation and high dose-rate approaches: GRID, Microbeam & FLASH radiotherapy. Br. J. Radiol. 93, 20200217 (2020).","journal-title":"Br. J. Radiol."},{"key":"1056_CR217","first-page":"150","volume":"3","author":"BW Loo Jr.","year":"2011","unstructured":"Loo, B. W. Jr. Stereotactic ablative radiotherapy (SABR) for lung cancer: what does the future hold? J. Thorac. Dis. 3, 150\u2013152 (2011).","journal-title":"J. Thorac. Dis."},{"key":"1056_CR218","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/09553002.2023.2295966","volume":"100","author":"J Thariat","year":"2024","unstructured":"Thariat, J. et al. Radiotherapy for non-cancer diseases: benefits and long-term risks. Int. J. Radiat. Biol. 100, 505-526 (2024).","journal-title":"Int. J. Radiat. Biol."},{"key":"1056_CR219","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175824","volume":"133","author":"PH Zushin","year":"2023","unstructured":"Zushin, P. H., Mukherjee, S. & Wu, J. C. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J. Clin. Invest. 133, e175824 (2023).","journal-title":"J. Clin. Invest."},{"key":"1056_CR220","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-021-00669-3","volume":"19","author":"M Nishiga","year":"2022","unstructured":"Nishiga, M., Liu, C., Qi, L. S. & Wu, J. C. The use of new CRISPR tools in cardiovascular research and medicine. Nat. Rev. Cardiol. 19, 505\u2013521 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1056_CR221","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.stem.2022.03.012","volume":"29","author":"H Kim","year":"2022","unstructured":"Kim, H., Kamm, R. D., Vunjak-Novakovic, G. & Wu, J. C. Progress in multicellular human cardiac organoids for clinical applications. Cell Stem Cell 29, 503\u2013514 (2022).","journal-title":"Cell Stem Cell"},{"key":"1056_CR222","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yjmcc.2021.04.006","volume":"157","author":"S Cho","year":"2021","unstructured":"Cho, S., Lee, C., Skylar-Scott, M. A., Heilshorn, S. C. & Wu, J. C. Reconstructing the heart using iPSCs: engineering strategies and applications. J. Mol. Cell. Cardiol. 157, 56\u201365 (2021).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1056_CR223","doi-asserted-by":"publisher","first-page":"122267","DOI":"10.1016\/j.biomaterials.2023.122267","volume":"301","author":"DN Tavakol","year":"2023","unstructured":"Tavakol, D. N. et al. Modeling and countering the effects of cosmic radiation using bioengineered human tissues. Biomaterials 301, 122267 (2023).","journal-title":"Biomaterials"},{"key":"1056_CR224","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.semcdb.2021.05.018","volume":"122","author":"JWS Jahng","year":"2021","unstructured":"Jahng, J. W. S., Zhang, M. & Wu, J. C. The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes. Semin. Cell Dev. Biol. 122, 56\u201365 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1056_CR225","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41592-022-01591-3","volume":"19","author":"S Cho","year":"2022","unstructured":"Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G. & Wu, J. C. Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nat. Methods 19, 1064\u20131071 (2022).","journal-title":"Nat. Methods"},{"key":"1056_CR226","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt, A. et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet 395, 1613\u20131626 (2020).","journal-title":"Lancet"},{"key":"1056_CR227","first-page":"002","volume":"S1","author":"DJ Krauss","year":"2014","unstructured":"Krauss, D. J. An overview of image-guided radiotherapy (IGRT). OMICS J. Radiol. S1, 002 (2014).","journal-title":"OMICS J. Radiol."},{"key":"1056_CR228","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrclinonc.2013.79","volume":"10","author":"JS Loeffler","year":"2013","unstructured":"Loeffler, J. S. & Durante, M. Charged particle therapy \u2014 optimization, challenges and future directions. Nat. Rev. Clin. Oncol. 10, 411\u2013424 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1056_CR229","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/0360-3016(85)90089-6","volume":"11","author":"EL Gillette","year":"1985","unstructured":"Gillette, E. L., McChesney, S. L. & Hoopes, P. J. Isoeffect curves for radiation-induced cardiomyopathy in the dog. Int. J. Radiat. Oncol. Biol. Phys. 11, 2091\u20132097 (1985).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1056_CR230","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0167-8140(92)90304-D","volume":"23","author":"SM Gillette","year":"1992","unstructured":"Gillette, S. M. et al. Late radiation response of canine mediastinal tissues. Radiother. Oncol. 23, 41\u201352 (1992).","journal-title":"Radiother. Oncol."},{"key":"1056_CR231","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0167-8140(92)90303-C","volume":"23","author":"S Schultz-Hector","year":"1992","unstructured":"Schultz-Hector, S., Sund, M. & Thames, H. D. Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother. Oncol. 23, 33\u201340 (1992).","journal-title":"Radiother. Oncol."},{"key":"1056_CR232","doi-asserted-by":"crossref","unstructured":"Chang, D. S., Lasley, F. D., Das, I. J., Mendonca, M. S. & Dynlacht, J. R. Basic Radiotherapy Physics and Biology (Springer, 2021).","DOI":"10.1007\/978-3-030-61899-5"},{"key":"1056_CR233","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","volume":"19","author":"G Sgouros","year":"2020","unstructured":"Sgouros, G., Bodei, L., McDevitt, M. R. & Nedrow, J. R. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat. Rev. Drug. Discov. 19, 589\u2013608 (2020).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1056_CR234","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1096\/fba.2020-00071","volume":"2","author":"M Lenarczyk","year":"2020","unstructured":"Lenarczyk, M. et al. Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: a role for the immune system. FASEB Bioadv. 2, 705\u2013719 (2020).","journal-title":"FASEB Bioadv."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01056-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:03:46Z","timestamp":1731488626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-024-01056-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":234,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1038\/s41569-024-01056-4","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"11 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C.W. is a co-founder of Greenstone Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}